Table III.
Ocular complications observed at presentation or during follow-up and comparison of proportions between the two periods
| Parameters | Group one (1995–2005) (n = 111) |
Group two (2006–2017) (n = 81) |
p-value |
|---|---|---|---|
| Macular edema | 22 (19.8) | 37 (45.6) | 0.001 |
| Macular hole | 3 (2.7) | 3 (3.7) | 0.69 |
| Epiretinal membrane | 22 (19.8) | 31 (38.27) | 0.17 |
| Cataract | 35 (31.5) | 27 (33.3) | 0.79 |
| Ocular hypertension | 9 (12.3) | 6 (7.4) | 0.3 |
| Disc/retinal neovascularization | 6 (5.4) | 4 (4.9) | 0.88 |
| Intravitreal hemorrhage | 4 (3.6) | 2 (2.4) | 0.65 |
| Neovascular glaucoma | 7 (6.3) | 1 (1.2) | 0.082 |
| Retinal detachment | 1 (0.9) | 1 (1.2) | 0.82 |
| Phthisis bulbi | 1 (0.9) | 1 (1.2) | 0.82 |
The data arepresented as no. of eyes (%).